Brain Factor-7® Improves Cognitive Impairment Following Transient Ischemia and Reperfusion Injury in Gerbil Forebrain through Promoting Remyelination and Restoring Cholinergic and Glutamatergic Neurotransmission in the Hippocampus

Front Biosci (Landmark Ed). 2022 Dec 28;27(12):337. doi: 10.31083/j.fbl2712337.

Abstract

Background: Ischemia and reperfusion injury in the brain triggers cognitive impairment which are accompanied by neuronal death, loss of myelin sheath and decline in neurotransmission. In this study, we investigated whether therapeutic administration of Brain Factor-7® (BF-7®; a silk peptide) in ischemic gerbils which were developed by transient (five minutes) ischemia and reperfusion in the forebrain (tFI/R) improved cognitive impairment.

Methods: Short-term memory and spatial memory functions were assessed by passive avoidance test and Barnes maze test, respectively. To examine neuronal change in the hippocampus, cresyl violet staining, immunohistochemistry for neuronal nuclei and fluoro Jade B histofluorescence were performed. We carried out immunohistochemistry for myelin basic protein (a marker for myelin) and receptor interacting protein (a marker for oligodendrocytes). Furthermore, immunohistochemistry for vesicular acetylcholine transporter (as a cholinergic transporter) and vesicular glutamate transporter 1 (as a glutamatergic synapse) was done.

Results: Administration of BF-7® significantly improved tFI/R-induced cognitive impairment. tFI/R-induced neuronal death was found in the Cornu Ammonis 1 (CA1) subfield of the hippocampus from five days after tFI/R. Treatment with BF-7® following tFI/R did not restore the death (loss) of CA1 neurons following tFI/R. However, BF-7® treatment to the ischemic gerbils significantly improved remyelination and proliferation of oligodendrocytes in the hippocampus with ischemic injury. Treatment with BF-7® to the ischemic gerbils significantly restored vesicular acetylcholine transporter-immunoreactive and vesicular glutamate transporter 1-immunoreactive structures in the hippocampus with ischemic injury.

Conclusions: Based on these results, we suggest that BF-7® can be utilized for improving cognitive impairments induced by ischemic injury as an additive for health/functional foods and/or medicines.

Keywords: cornu Ammonis 1; memory function; neurotransmission; oligodendrocytes; pyramidal neuron; silk peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia* / metabolism
  • Cholinergic Agents / analysis
  • Cholinergic Agents / metabolism
  • Cognitive Dysfunction* / drug therapy
  • Gerbillinae / metabolism
  • Hippocampus
  • Ischemia / metabolism
  • Ischemic Attack, Transient* / metabolism
  • Prosencephalon / metabolism
  • Remyelination*
  • Reperfusion Injury* / drug therapy
  • Reperfusion Injury* / metabolism
  • Synaptic Transmission
  • Vesicular Acetylcholine Transport Proteins / analysis
  • Vesicular Acetylcholine Transport Proteins / metabolism
  • Vesicular Glutamate Transport Protein 1 / analysis
  • Vesicular Glutamate Transport Protein 1 / metabolism

Substances

  • Vesicular Acetylcholine Transport Proteins
  • Vesicular Glutamate Transport Protein 1
  • Cholinergic Agents